Patent intelligence · US
US 7169411
Composition for delivery of biological agents and methods for the preparation thereof
Composition for delivery of biological agents and methods for the preparation thereof
Patent details — US 7169411
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 30, 2007
- Expiration
- Jan 25, 2027
- Applicant
- UNIVERSITY OF NEBRASKA BOARD OF REGENTS
- Claims
- 23
- CPC classes
- A61K, A61K47/542, A61K47/543, A61K47/545
Quick answer
US 7169411 (Composition for delivery of biological agents and methods for the preparation thereof) is held by UNIVERSITY OF NEBRASKA BOARD OF REGENTS. Status: granted. Granted Jan 30, 2007. Expires Jan 25, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- UNIVERSITY OF NEBRASKA BOARD OF REGENTS
- Grant date
- Expiration
- Claims
- 23
- CPC classes
- A61K, A61K47/542, A61K47/543, A61K47/545, A61K47/58, A61K47/59
More from UNIVERSITY OF NEBRASKA BOARD OF REGENTS
Related pharmaceutical patents in our USPTO index.
-
US 12428463
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted
Frequently asked questions
What is US patent 7169411?
US 7169411 (Composition for delivery of biological agents and methods for the preparation thereof) is held by UNIVERSITY OF NEBRASKA BOARD OF REGENTS. Status: granted. Granted Jan 30, 2007. Expires Jan 25, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7169411?
UNIVERSITY OF NEBRASKA BOARD OF REGENTS is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.
When does US 7169411 expire?
Our index shows an expiration date of Jan 25, 2027 (1 year from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.